title: Virus-vectored influenza virus vaccines.
abstract: Despite the availability of an inactivated vaccine that has been licensed for >50 years, the influenza virus continues to cause morbidity and mortality worldwide. Constant evolution of circulating influenza virus strains and the emergence of new strains diminishes the effectiveness of annual vaccines that rely on a match with circulating influenza strains. Thus, there is a continued need for new, efficacious vaccines conferring cross-clade protection to avoid the need for biannual reformulation of seasonal influenza vaccines. Recombinant virus-vectored vaccines are an appealing alternative to classical inactivated vaccines because virus vectors enable native expression of influenza antigens, even from virulent influenza viruses, while expressed in the context of the vector that can improve immunogenicity. In addition, a vectored vaccine often enables delivery of the vaccine to sites of inductive immunity such as the respiratory tract enabling protection from influenza virus infection. Moreover, the ability to readily manipulate virus vectors to produce novel influenza vaccines may provide the quickest path toward a universal vaccine protecting against all influenza viruses. This review will discuss experimental virus-vectored vaccines for use in humans, comparing them to licensed vaccines and the hurdles faced for licensure of these next-generation influenza virus vaccines.
authors.affiliation: Department of Infectious Diseases, University of Georgia, 111 Carlton St., Athens, GA 30602, USA. ratripp@uga.edu.
authors.forename: Ralph A
authors.initials: RA
authors.lastname: Tripp
authors.affiliation: Department of Infectious Diseases, University of Georgia, 111 Carlton St., Athens, GA 30602, USA. smt@uga.edu.
authors.forename: S Mark
authors.initials: SM
authors.lastname: Tompkins
mesh_terms: D004337:Drug Carriers; D055808:Drug Discovery / Q000639:trends; D005822:Genetic Vectors; D006801:Humans; D007252:Influenza Vaccines / Q000235:genetics / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control; D009975:Orthomyxoviridae / Q000235:genetics / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology
chemical_list: D004337:Drug Carriers; D007252:Influenza Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic
references.citation: Proc Natl Acad Sci U S A. 1983 Dec;80(23):7155-9
references.pmid: 6580632
references.citation: Nature. 1984 Oct 11-17;311(5986):578-9
references.pmid: 6332992
references.citation: Curr Top Microbiol Immunol. 2009;333:243-67
references.pmid: 19768410
references.citation: J Infect Dis. 2011 Mar 15;203(6):753-5
references.pmid: 21343145
references.citation: Sci Transl Med. 2013 May 29;5(187):187ra72
references.pmid: 23720583
references.citation: Nat Rev Microbiol. 2010 Jan;8(1):62-73
references.pmid: 19966816
references.citation: Virology. 2007 May 25;362(1):139-50
references.pmid: 17254623
references.citation: J Virol. 1998 Jun;72(6):4704-11
references.pmid: 9573234
references.citation: Vaccine. 2009 Nov 5;27(47):6512-21
references.pmid: 19729082
references.citation: Emerg Med Clin North Am. 2003 May;21(2):353-61
references.pmid: 12793618
references.citation: Vaccine. 1999 Feb 5;17(5):497-507
references.pmid: 10073729
references.citation: Vet Res. 2004 Jul-Aug;35(4):425-43
references.pmid: 15236675
references.citation: Poult Sci. 2003 Jun;82(6):899-906
references.pmid: 12817444
references.citation: Clin Microbiol Rev. 2007 Jul;20(3):489-510, table of contents
references.pmid: 17630337
references.citation: Braz J Med Biol Res. 2005 Apr;38(4):509-22
references.pmid: 15962176
references.citation: Mol Pharm. 2007 Jan-Feb;4(1):18-32
references.pmid: 17274663
references.citation: PLoS One. 2013 Aug 22;8(8):e73313
references.pmid: 23991187
references.citation: J Virol. 2008 Mar;82(6):2975-88
references.pmid: 18184713
references.citation: Nat Biotechnol. 2013 Jul;31(7):647-52
references.pmid: 23728362
references.citation: J Infect Dis. 2012 Jul 15;206(2):258-66
references.pmid: 22561365
references.citation: Clin Infect Dis. 2012 Jul;55(1):19-25
references.pmid: 22441650
references.citation: Vaccine. 2005 Jan 11;23(8):1029-36
references.pmid: 15620476
references.citation: Avian Dis. 2003;47(3 Suppl):1047-50
references.pmid: 14575108
references.citation: J Virol. 1998 Aug;72(8):6907-10
references.pmid: 9658144
references.citation: Virology. 2008 Oct 25;380(2):412-20
references.pmid: 18786689
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11349-53
references.pmid: 8876138
references.citation: Virology. 2007 Sep 15;366(1):166-73
references.pmid: 17524441
references.citation: PLoS One. 2014 Feb 11;9(2):e88340
references.pmid: 24523886
references.citation: Trends Biotechnol. 2002 Apr;20(4):173-80
references.pmid: 11906750
references.citation: J Virol. 2013 May;87(10):5985-93
references.pmid: 23514880
references.citation: Rev Med Virol. 2002 Sep-Oct;12(5):279-96
references.pmid: 12211042
references.citation: Hum Vaccin Immunother. 2012 Jan;8(1):34-44
references.pmid: 22252001
references.citation: Lancet. 2008 Nov 29;372(9653):1894-1905
references.pmid: 19012957
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2046-51
references.pmid: 18270165
references.citation: Vaccine. 2013 Feb 27;31(10):1385-92
references.pmid: 23328313
references.citation: Clin Microbiol Rev. 2008 Oct;21(4):583-93
references.pmid: 18854481
references.citation: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8197-202
references.pmid: 16717197
references.citation: J Virol. 2009 Dec;83(24):12738-50
references.pmid: 19812149
references.citation: Vaccine. 2004 Sep 3;22(25-26):3427-34
references.pmid: 15308368
references.citation: Clin Infect Dis. 2005 Jun 1;40(11):1693-6
references.pmid: 15889371
references.citation: Vaccine. 2005 Nov 16;23(46-47):5404-10
references.pmid: 16011865
references.citation: Mil Med. 1995 Jun;160(6):300-4
references.pmid: 7659229
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10847-51
references.pmid: 1438287
references.citation: Science. 1999 Dec 17;286(5448):2244-5
references.pmid: 10636774
references.citation: Antiviral Res. 2011 Dec;92(3):493-6
references.pmid: 22020305
references.citation: Vaccine. 2003 May 1;21(16):1776-9
references.pmid: 12686093
references.citation: Virology. 2000 Dec 5;278(1):55-9
references.pmid: 11112481
references.citation: Nat Rev Genet. 2003 May;4(5):346-58
references.pmid: 12728277
references.citation: Curr Top Microbiol Immunol. 1992;176:119-30
references.pmid: 1600749
references.citation: PLoS One. 2009 Aug 05;4(8):e6509
references.pmid: 19654873
references.citation: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8203-8
references.pmid: 16717196
references.citation: Virology. 1992 May;188(1):217-32
references.pmid: 1566575
references.citation: J Gen Virol. 1999 Nov;80 ( Pt 11):2987-2995
references.pmid: 10580061
references.citation: PLoS One. 2013 Apr 30;8(4):e62496
references.pmid: 23638099
references.citation: Proc Natl Acad Sci U S A. 1982 Dec;79(23):7415-9
references.pmid: 6296831
references.citation: J Virol. 1968 Aug;2(8):778-86
references.pmid: 5701819
references.citation: J Immunol. 2003 Aug 1;171(3):1133-9
references.pmid: 12874198
references.citation: J Virol. 1999 Jun;73(6):5001-9
references.pmid: 10233962
references.citation: Curr Top Microbiol Immunol. 2009;333:43-82
references.pmid: 19768400
references.citation: MMWR Recomm Rep. 2013 Sep 20;62(RR-07):1-43
references.pmid: 24048214
references.citation: Vaccine. 2014 Apr 17;32(19):2225-30
references.pmid: 24613525
references.citation: PLoS Pathog. 2009 Jun;5(6):e1000480
references.pmid: 19543380
references.citation: Gene Ther. 2005 Oct;12 Suppl 1:S62-72
references.pmid: 16231057
references.citation: Crit Care. 2010;14(2):218
references.pmid: 20497595
references.citation: Vaccine. 2005 Jul 8;23 Suppl 1:S10-25
references.pmid: 15908062
references.citation: Methods Enzymol. 2012;507:229-54
references.pmid: 22365777
references.citation: Virology. 2007 Mar 30;360(1):36-49
references.pmid: 17098273
references.citation: Vaccine. 2008 Sep 12;26 Suppl 4:D49-53
references.pmid: 19230160
references.citation: J Virol. 2013 Jan;87(1):363-71
references.pmid: 23077318
references.citation: Viruses. 2012 Nov 01;4(11):2711-35
references.pmid: 23202501
references.citation: N Engl J Med. 1972 Jun 22;286(25):1329-32
references.pmid: 5027388
references.citation: Clin Exp Vaccine Res. 2014 Jan;3(1):12-28
references.pmid: 24427759
references.citation: Virology. 1987 Oct;160(2):336-45
references.pmid: 3310381
references.citation: Clin Infect Dis. 2011 Jan 1;52(1):1-7
references.pmid: 21148512
references.citation: Hum Gene Ther. 2001 Jun 10;12(9):1047-61
references.pmid: 11399227
references.citation: Vaccine. 2009 Dec 11;28(2):484-93
references.pmid: 19857446
references.citation: Vaccine. 2001 Aug 14;19(31):4373-7
references.pmid: 11483261
references.citation: PLoS One. 2010 Dec 16;5(12):e15301
references.pmid: 21179494
references.citation: Vaccine. 2009 Apr 6;27(16):2258-64
references.pmid: 19428840
references.citation: mBio. 2010 May 18;1(1):
references.pmid: 20689752
references.citation: Arch Virol. 2002 Nov;147(11):2125-41
references.pmid: 12417948
references.citation: MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62
references.pmid: 20689501
references.citation: Front Immunol. 2014 Jan 21;5:5
references.pmid: 24478774
references.citation: J Virol. 2010 Feb;84(3):1489-503
references.pmid: 19923177
references.citation: PLoS One. 2012;7(8):e44447
references.pmid: 22952980
references.citation: Infect Chemother. 2013 Dec;45(4):375-86
references.pmid: 24475351
references.citation: J Virol. 2006 Jun;80(12):6033-47
references.pmid: 16731942
references.citation: J Virol. 1997 Aug;71(8):5982-9
references.pmid: 9223488
references.citation: J Virol. 2011 May;85(9):4602-5
references.pmid: 21325423
references.citation: J Infect Dis. 1974 Apr;129(4):411-20
references.pmid: 4593871
references.citation: J Infect Dis. 2013 Mar 15;207(6):974-81
references.pmid: 23307936
references.citation: Vaccine. 1994 Aug;12(11):1032-40
references.pmid: 7975844
references.citation: J Virol. 2001 Dec;75(23):11868-73
references.pmid: 11689668
references.citation: Virology. 1997 Dec 22;239(2):389-401
references.pmid: 9434729
references.citation: Virology. 1997 Feb 17;228(2):153-60
references.pmid: 9123821
references.citation: PLoS One. 2012;7(2):e31177
references.pmid: 22363572
references.citation: J Virol. 1999 May;73(5):3723-32
references.pmid: 10196265
references.citation: PLoS One. 2012;7(10):e48322
references.pmid: 23118984
references.citation: J Exp Med. 1937 Jun 30;66(1):15-34
references.pmid: 19870647
references.citation: J Virol. 2011 Jan;85(1):217-30
references.pmid: 20980507
references.citation: Expert Rev Vaccines. 2010 Nov;9(11):1325-41
references.pmid: 21087110
references.citation: J Virol. 2010 May;84(9):4611-8
references.pmid: 20181720
references.citation: J Virol. 2013 Aug;87(16):9290-300
references.pmid: 23785204
references.citation: Mol Immunol. 2009 Jul;46(11-12):2210-7
references.pmid: 19446339
references.citation: Vaccine. 1995 Sep;13(13):1143-51
references.pmid: 8578797
references.citation: Virus Res. 2004 Jul;103(1-2):177-85
references.pmid: 15163507
references.citation: Lancet. 2008 Nov 29;372(9653):1881-1893
references.pmid: 19012954
references.citation: DNA Cell Biol. 2002 Dec;21(12):895-913
references.pmid: 12573049
references.citation: J Gen Virol. 2008 Dec;89(Pt 12):2992-2997
references.pmid: 19008384
references.citation: Vaccine. 2012 Dec 17;31(1):190-5
references.pmid: 23107591
references.citation: Paediatr Drugs. 2004;6(4):199-209
references.pmid: 15339199
references.citation: Vaccine. 2013 Sep 6;31(39):4223-30
references.pmid: 23746455
references.citation: J Virol. 2013 Jan;87(1):354-62
references.pmid: 23077314
references.citation: Proc (Bayl Univ Med Cent). 2005 Jan;18(1):21-5
references.pmid: 16200144
references.citation: JAMA. 2004 Sep 15;292(11):1333-40
references.pmid: 15367555
references.citation: MMWR Recomm Rep. 2011 Jan 21;60(1):1-24
references.pmid: 21248682
references.citation: Avian Dis. 2011 Sep;55(3):413-21
references.pmid: 22017039
references.citation: Antiviral Res. 2010 May;86(2):180-7
references.pmid: 20153776
references.citation: Proc Natl Acad Sci U S A. 1982 Aug;79(16):4927-31
references.pmid: 6289324
references.citation: Vaccine. 2013 Sep 6;31(39):4235-40
references.pmid: 23523402
references.citation: PLoS One. 2011;6(7):e21937
references.pmid: 21789196
references.citation: J Virol. 1997 Oct;71(10):7960-2
references.pmid: 9311887
references.citation: J Virol. 2007 Nov;81(21):11560-8
references.pmid: 17715243
references.citation: Antiviral Res. 2013 Jun;98(3):476-83
references.pmid: 23583287
references.citation: Expert Opin Biol Ther. 2010 Oct;10(10):1469-87
references.pmid: 20822477
references.citation: Annu Rev Med. 2013;64:189-202
references.pmid: 23327522
references.citation: PLoS One. 2010 Mar 23;5(3):e9812
references.pmid: 20352112
references.citation: Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9
references.pmid: 3872457
references.citation: J Gen Virol. 1986 Apr;67 ( Pt 4):719-26
references.pmid: 3485697
references.citation: PLoS One. 2012;7(11):e50144
references.pmid: 23185558
references.citation: Curr Opin Infect Dis. 2004 Apr;17(2):127-30
references.pmid: 15021052
references.citation: Natl Vital Stat Rep. 2005 Feb 28;53(15):1-48
references.pmid: 15779680
references.citation: Vaccine. 2010 Jan 8;28(3):790-7
references.pmid: 19887135
references.citation: J Virol. 2007 Jan;81(1):150-8
references.pmid: 17050610
references.citation: Ann N Y Acad Sci. 2006 Oct;1081:193-201
references.pmid: 17135511
references.citation: Trends Mol Med. 2004 May;10(5):210-6
references.pmid: 15121047
references.citation: Vaccine. 2006 Feb 13;24(7):849-62
references.pmid: 16297508
references.citation: J Virol. 1986 Mar;57(3):786-91
references.pmid: 3485199
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3722-7
references.pmid: 16505353
references.citation: Future Virol. 2013 Jan 1;8(1):25-41
references.pmid: 23440999
references.citation: Emerg Infect Dis. 2007 Mar;13(3):426-35
references.pmid: 17552096
references.citation: J Clin Invest. 2010 Sep;120(9):3234-41
references.pmid: 20679728